Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial

The Lancet

Volumn 387, Issue 10019, 2016, Pages 649-660

  Costeloe, Kate ^a   Hardy, Pollyanna ^b   Juszczak, Edmund ^b   Wilks, Mark ^c   Millar, Michael R ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BBG 001; BIFIDOBACTERIUM BREVE EXTRACT; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MILK; BIRTH; BLOOD CULTURE; CHILD DEATH; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NECROTIZING ENTEROCOLITIS; PHASE 3 CLINICAL TRIAL; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; ADULT; BIFIDOBACTERIUM; BIRTH WEIGHT; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; ENTEROCOLITIS, NECROTIZING; GRAM-POSITIVE BACTERIAL INFECTIONS; INFANT, PREMATURE, DISEASES; MALE; MATERNAL AGE; NEWBORN; TREATMENT OUTCOME;

ADULT; BIFIDOBACTERIUM; BIRTH WEIGHT; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENTEROCOLITIS, NECROTIZING; FEMALE; GESTATIONAL AGE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; MATERNAL AGE; PROBIOTICS; SEPSIS; TREATMENT OUTCOME;

EID: 84957845119     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)01027-2     Document Type: Article

References (36)

1. JE Berrington, RI Hearn, M Bythell, C Wright, ND Embleton Deaths in preterm infants: changing pathology over 2 decades J Pediatr 160 2012 49 53
2. I Adams-Chapman Long-term impact of infection on the preterm neonate Semin Perinatol 36 2012 462 470
3. MP Sherman New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention Clin Perinatol 37 2010 565 579
4. RM Torrazza, M Ukhanova, X Wang et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis PLoS One 8 2014 e83304
5. K Alfaleh, J Anabrees, D Bassler, T Al-Kharfi Probiotics for prevention of necrotizing enterocolitis in preterm infants Cochrane Database Syst Rev 3 2014 CD005496.
6. WA Mihatsch, CP Braegger, T Decsi et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants Clin Nutr 31 2012 6 15
7. Medicines and Healthcare products Regulatory Agency A guide to what is a medicinal product'. MHRA Guidance Note No 8 https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/398998/A-guide-to-what-is-a-medicinal-product.pdf 2012 (accessed Nov 19, 2015).
8. J Fujimoto, K Tanigawa, Y Kudo, H Makino, K Watanabe Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide J Appl Microbiol 110 2011 20917
9. MJ Bell, JL Ternberg, RD Feigin et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based on clinical staging Ann Surg 187 1978 1 7
10. MC Walsh, RM Kliegman Necrotizing enterocolitis: treatment based on staging criteria Pediatr Clin North Am 33 1986 179 201
11. JV Freeman, TJ Cole, S Chinn, PRM Jones, EM White, MA Preece Cross sectional stature and weight reference curves for the UK, 1990 Arch Dis Child 73 1995 17 24
12. StataCorp Stata Statistical Software: Release 13 2013 StataCorp LP College Station, TX
13. AH Jobe, E Bancalari NICHD/NHLBI/ORD Workshop Summary: Bronchopulmonary Dysplasia Am J Respir Crit Care Med 163 2001 1723 1729
14. H Kitajima, Y Sumida, R Tanaka, N Yuki, H Takayama, M Fujimura Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial Arch Dis Childh Fetal Neonatal Ed 76 1997 F101 F107
15. EC Claud, WA Walker Bacterial colonization, probiotics and necrotizing enterocolitis J Clin Gastroenterol 42 2008 S46 S52
16. M O'Connell Motherway, A Zomer, SC Leahy et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor Proc Natl Acad Sci 108 2011 11217 11222
17. M Ventura, F Turroni, M O'Connell Motherway, J MacSharry, D van Sinderen Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria Trends Microbiol 20 2012 467 476
18. MS Cilieborg, M Boye, PT Sangild Bacterial colonization and gut development in preterm neonates Early Hum Dev 88 2012 S41 S49
19. BJ Stoll, NI Hansen, EF Bell et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network Pediatrics 126 2010 443 456
20. SE Jacobs, JM Tobin, GF Opie et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial Pediatrics 132 2013 1055 1062
21. G Deshpande, S Rao, S Patole, M Bulsara Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates Pediatrics 125 2010 921 930
22. CN Jacobsen, V Rosenfeldt Nielsen, AE Hayford et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp by in vitro techniques and evaluation of the colonization ability of five selected strains in humans Appl Environ Microbiol 65 1999 4949 4956
23. CL Ohland, WK MacNaughton Probiotics and intestinal barrier function Am J Physiol Gastrointest Liver Physiol 298 2010 G807 G819
24. MA Underwood, KM Kalanetra, NA Bokulich et al. A comparison of two probiotic strains of Bifidobacteria in premature Infants J Pediatrics 163 2013 1585 1591
25. HC Lin, BH Su, AC Chen et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants Pediatrics 115 2005 1 4
26. A Bin-Nun, R Bromiker, M Wilschanski et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates J Pediatrics 147 2005 192 196
27. H-C Lin, C-H Hsu, H-L Chen et al. Oral probiotics prevent necrotising enterocolitis in very low birth weight infants: a multi-centre, randomized controlled trial Pediatrics 122 2008 693 700
28. M Samanta, M Sarkar, P Ghosh, J Ghosh, M Sinha, S Chatterjee Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns J Trop Pediatr 55 2009 128 131
29. WO Tarnow-Mordi, D Wilkinson, A Trivedi, J Brok Probiotics reduce all-cause mortality and necrotising enterocolitis: is it time to change practice? Pediatrics 125 2010 1068
30. RF Soll Probiotics: Are we ready for routine use? Pediatrics 125 2010 1071 1072
31. Q Wang, J Dong, Y Zhu Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials J Pediatr Surg 47 2012 241 248
32. C Bertelli, T Pillonel, A Torregrossa et al. Bifidobacterium longum bacteraemia in preterm infants receiving probiotics Clin Infect Dis 60 2015 924 927
33. A Zbinden, R Zbinden, C Berger, Arlettaz Case series of Bifidobacterium longum bacteraemia in three preterm infants on probiotic therapy Neonatology 107 2015 56 59
34. US Centers for Disease Control and Prevention Fatal gastrointestinal mucormycosis in an infant following ingestion of contaminated dietary supplement - Connecticut, 2014 http://emergency.cdc.gov/han/han00373.asp (accessed Nov 19, 2015).
35. MK Gibson, MW Pesesky, G Dantas The yin and yang of bacterial resilience in the human gut microbiota J Mol Biol 426 2014 3866 3876
36. D Chrzanowska-Liszewska, J Seliga-Siwecka, MK Kornacka The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial Early Hum Dev 88 2012 57 60